Pro Medicus Limited (ASX:PME) Insider Anthony Glenning Buys 50 Shares

Pro Medicus Limited (ASX:PME) insider Anthony Glenning acquired 50 shares of the business’s stock in a transaction that occurred on Wednesday, March 12th. The stock was bought at an average cost of A$219.58 ($138.10) per share, for a total transaction of A$10,979.00 ($6,905.03).

Pro Medicus Price Performance

The company has a debt-to-equity ratio of 1.10, a quick ratio of 4.39 and a current ratio of 5.98. The company has a market cap of $29.16 billion, a P/E ratio of 351.99, a price-to-earnings-growth ratio of 3.87 and a beta of 0.56.

Pro Medicus Increases Dividend

The business also recently announced a Interim dividend, which will be paid on Thursday, March 20th. Investors of record on Thursday, March 20th will be paid a dividend of $0.25 per share. The ex-dividend date is Wednesday, February 26th. This is a positive change from Pro Medicus’s previous Interim dividend of $0.18. This represents a yield of 0.09%. Pro Medicus’s dividend payout ratio is currently 56.41%.

Pro Medicus Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.